This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Submucosal Injections Market

Market Insights on Submucosal Injections covering sales outlook, demand forecast & up-to-date key trends

Submucosal Injections Market : Global Industry Analysis 2016 - 2020 and Opportunity Assessment 2021 - 2031

Submucosal Injections Market Overview

According to the latest research by FMI, submucosal injections is set to witness a 7.3% growth during the year 2021-2031. The global demand for submucosal injections is expected to grow at a moderate pace during the forecast period. The submucosal injections are required principally during the endoscopic mucosal resection techniques.

They are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus. The most common submucosal agents are dextrose water, hydroxypropyl methylcellulose, normal saline, hyaluronic acid, hydroxyethyl starch and Orise gel.

What is Driving Demand for Submucosal Injections?

Submucosal injections are an indispensable part of endoscopic submucosal dissection. Thus the submucosal injections are expected to grow in value by commonly being used in the treatment of diseases such as cancers (esophageal, small intestine and gastric), polyps in the colon and Barrett’s esophagus.

The use of these injections thus accounts for the minimization of adverse effects and untangles polypectomy. The rise in the application of submucosal injections is attributed to the increasing cases of several cancer types and their use in surgeries for the helpful removal of cancer cells before their growth. The factor of this technique being less invasive allows greater adoption of submucosal injections.

Customize this Report

Let us know your requirement to get
100% FREE customization

Which Factors are Likely to Augment Growth of Submucosal Injection Adoption?

The augmentative factors which are expected to propel the development of submucosal injections are the increasing demand for endoscopic procedures, especially in the developed economies. Additionally, the rise in the number of patients with the intention of seeking treatment for early stage stomach cancer or premature cancer has also assisted with the increased growth and demand for submucosal injections.

Also, the introduction of new submucosal lifting agents such as, the development of Eleview by Cosmo Pharmaceuticals N.V., which is a ready-to-use and safe submucosal lifting agent, has led to advanced research and adoption of submucosal injections.

US and Canada Submucosal Injections Outlook

The submucosal injections value is likely to experience a lucrative growth in the region of North America. The countries US and Canada amount to the largest share in the submucosal injections application. According to the US National Cancer Institute, cancer incidence rate is 442.4 per 100,0000 men and women per year.

The increasing cases of several cancer types which include gastro, esophageal and colorectal cancers in these countries has accounted for the increase in demand of submucosal injections. Additionally, the demand is also gaining traction because of advanced healthcare infrastructure as well as favorable reimbursement policies in North America.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Europe Demand Outlook for Submucosal injections

The Europe submucosal injections sales is set to gain significant traction due to the increasing healthcare expenditure. The incidence rate of primarily esophageal cancer in the U.K. and Netherlands is highly standardized. The advancement of technology in terms of treatment of early stomach cancer, intestinal cancer and esophageal cancer is set to advance the European submucosal injections growth.

Who are the Key Manufacturers and Suppliers of Submucosal injections?

The key manufacturers of the submucosal injections are

  • Bio Space Inc.
  • GI Supply Cosmo Pharmaceuticals N.V.
  • FUJIFILM Medical Systems
  • Medtronic Plc.
  • Zeon Medical
  • Boston Scientific
  • Aries Pharmaceuticals
  • Sumitomo Bakelite Co.
  • ERBE Elektromedizin GmbH
  • Ovesco Endoscopy AG
  • Ovesco Endoscopy AG
  • Olympus Corporation
  • Pharmascience Inc.
  • FUJIFILM Medical Systems, Inc.

The key players use patented advancements and hold a dominating position in production and marketing of submucosal injections. Moreover, high R&D activities and new product advancements cater to the company rank and position.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.

The report also maps the qualitative impact of various market factors on market segments and geographies.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments

By Type of Agent:

  • Eleview and ORISE gel®
  • Normal saline
  • Dextrose water
  • Hydroxyethyl starch
  • Hydroxypropyl methylcellulose
  • Succinylated gelatin
  • Hyaluronic acid
  • Fibrinogen mixture

By Application:

  • Colorectal Cancer
  • Gastric Cancer
  • Esophageal Cancer

By End User:

  • Hospitals
  • Surgical Centers
  • Others

By Region:

  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • U.K.
    • Spain
    • BENELUX
    • Russia
  • South Asia
    • India
    • Thailand
    • Malaysia
    • Indonesia
    • Rest of South Asia
  • East Asia
  • China
  • Japan
  • South Korea
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Turkey
Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Submucosal Injections Market